Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01952847 · ClinicalTrials.gov registry record · Phase 3
Randomized Trial of Glutamine in Patients With Mucositis or Esophagitis
A Phase 3 study, sponsored by M.D. Anderson Cancer Center.
- Terminated
- Registry status
- Phase 3
- Development phase
- 77
- Enrollment target
NCT01952847: Clinical Trial Phase 3 study, sponsored by M.D. Anderson Cancer Center.
NCT01952847 is a Phase 3 study that was terminated before completion, run by M.D. Anderson Cancer Center. The registered enrollment target is 77 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01952847, a Phase 3 study, was terminated before completion, sponsored by M.D. Anderson Cancer Center.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 77 participants
- Enrollment target
Study Summary
The goal of this clinical research study is to learn if glutamine can help control and prevent sores, blisters, or inflammation in your mouth or esophagus due to your current treatment. In this study, glutamine will be compared to a placebo. A placebo is not a drug. It looks like the drug but is not designed to treat any disease or illness. It is designed to be compared with a study drug to learn if the study drug has any real effect.
Interventions
- OTHER Placebo
- BEHAVIORAL Questionnaires
- DRUG Glutamine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 77 participants |
| Start Date | 2014-07-10 |
| Est. Completion | 2021-03-03 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01952847
The ClinicalTrials.gov registry entry for NCT01952847 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 77 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT01952847 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01952847 about?
NCT01952847 is a clinical study titled "Randomized Trial of Glutamine in Patients With Mucositis or Esophagitis". The goal of this clinical research study is to learn if glutamine can help control and prevent sores, blisters, or inflammation in your mouth or esophagus due to your current treatment. In this study, glutamine will be compared to a placebo. A placebo is not a drug. It looks like the drug but is no...
What is the current status of trial NCT01952847?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 77 participants. The study started on 2014-07-10. Estimated completion is 2021-03-03.
What interventions are being tested in trial NCT01952847?
The interventions under investigation include: Placebo (OTHER), Questionnaires (BEHAVIORAL), Glutamine (DRUG).
Who is sponsoring clinical trial NCT01952847?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.